2013评委奖

我们感谢我们的专业知识,并把卫生组织的创新,医疗保健经验和宣传,我们的评奖过程的专家小组。

劳伦·巴恩斯,MHS 高级副总裁,报销 -  Avalere健康

劳伦·巴恩斯是Avalere报销健康的高级副总裁,提供战略规划和公共政策付款人的专业知识给客户,以帮助其产品的成功商业化。她建议客户在制药和生物技术行业。

毫秒。巴恩斯是支付和行业总监安进公司,她在那里工作了六年。而在安进,毫秒。巴恩斯举行了一系列的领导作用和政策内的报销砂。她带领Amgen公司内部的薪酬政策和分析团队,以及安进的医疗补助和医疗领域的团队。毫秒。巴恩斯开始了她的职业生涯安进公司在华盛顿特区的政府事务办公室。紧接她的时间与Amgen公司,她为中心的医疗保险和她开发出在覆盖面和分析小组医保用药范围的政策补助服务(前身为HCFA)。此外,毫秒。巴恩斯是癌症支持社区的董事会成员。毫秒。巴恩斯持有公共卫生学士学位和约翰霍普金斯大学的医疗保健政策的MHS。

www.avalerehealth.net

瓦莱丽·弗莱什曼,工商管理硕士 执行董事 - NEHI

瓦莱丽弗莱什曼提供用于NEHI战略和操作方向。作为执行董事,她负责该研究所的研究政策,计划,运作,筹款和通信。在她的领导,NEHI的计划寻求提高慢性疾病护理,疾病预防和健康促进,加快采纳整个医疗系统有价值的创新。她撰写了广泛的卫生政策问题的许多报告,简报和文章。

Ms. Fleishman joined NEHI at its founding in 2002, and has over fifteen years’ experience in health care, health policy, technology and innovation. Prior to joining NEHI, Ms. Fleishman was a director in Health and Wellness at Scient Corporation, where she led strategic consulting engagements with leading biotechnology, medical device and pharmaceutical clients in areas such as telemedicine, disease management, health information technology, clinical trials, and sales and marketing strategies. Previously, Ms. Fleishman was a manager in Arthur D. Little’s Global Strategy Practice. Ms. Fleishman also worked in product management and brand marketing at Johnson & Johnson’s McNeil Consumer Products. Ms. Fleishman received her BA, cum laude, from Harvard University and her MBA from the Harvard Business School. In 2008, she was honored as one of Boston’s “40 under 40″ by the Boston Business Journal.

www.nehi.net

凯西拉图, 特约编辑 -  治疗杂志 

浸润性乳腺癌诊断于1986年,凯西·拉图尔了乳房切除术和化疗,并在全国社区的幸存者已-活跃,说话的幸存者,医疗和非专业观众关于是否需要心理支持。毫秒。拉图尔经历了乳癌的2007年秋季第二乳房切除她的书RESULTING的第二诊断,患乳腺癌的伴侣是由威廉·莫罗和合作出版。在1993年。

于2001年共同创办,她治愈杂志与王志祥博士。维奈耆那教。如今,她是特约编辑出版,这是该国最大的直接向癌症患者杂志。她写在她的癌症已经获得了众多奖项,包括对待来自卫生保健新闻工作者协会第一次发生在2011年她的文章的生活成本,这在辐射的长期存活后期特效看着。

在2004年,她推出了她一个女人秀“一个突变细胞,”幽默而凄美的帐户,通过乳腺癌她的旅程,她已经为各种全国各地的癌症事件进行了超过50次。她担任了四年的全国癌症幸存者联盟的董事会成员,并帮助发现吉尔达俱乐部北德州,现在被称为癌症支持社区北德州。此外,她在创始在达拉斯桥乳房网络工具,乳腺癌幸存者和区域医疗保健专家独特的联盟是没有保险的女人身上,她们有乳腺癌的诊断提供和世界卫生组织治疗。

www.curetoday.com

马克ALLES执行副总裁, 血液学和肿瘤学的全球主管 Celgene公司

Mark Alles became the Executive Vice President and 血液学和肿瘤学的全球主管 in December of 2012 following his promotion to Chief Commercial Officer of Celgene公司 in January 2012. Mr. Alles joined Celgene in April 2004 and served as Vice President, Global Marketing until March 2009 when he became President of the Americas Region. 责任 for operations in 日本 and Asia Pacific Region was added in July 2011. Mr. Alles previously served as Vice President for the US Oncology Business Unit of Aventis Pharmaceuticals and in other commercial sales and marketing management roles over an 11 year period. After earning his BS degree from Lock Haven University of Pennsylvania and serving as a Captain in the United State Marine Corps, he started his twenty-six year career in the pharmaceutical industry at Bayer and worked at Centocor before its acquisition by Johnson & Johnson. Mr. Alles currently serves as a non-paid Director for Gilda’s Club NYC and is on the Healthcare Institute of New Jersey’s Board of Trustees.

www.celgene.com

“如果你想新的东西,你必须停止做旧的东西。”

- 彼得·F。德鲁克,作家和管理顾问